Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Hans van Snellenberg"'
Autor:
Kris G Samsom, Luuk J Schipper, Paul Roepman, Linda JW Bosch, Ferry Lalezari, Elisabeth G Klompenhouwer, Adrianus J de Langen, Tineke E Buffart, Immy Riethorst, Lieke Schoenmaker, Daoin Schout, Vincent van der Noort, Jose G van den Berg, Ewart de Bruijn, Jacobus JM van der Hoeven, Hans van Snellenberg, Lizet E van der Kolk, Edwin Cuppen, Emile E Voest, Gerrit A Meijer, Kim Monkhorst
Publikováno v:
Journal of Pathology, 258(2), 179-188. John Wiley and Sons Ltd
Samsom, K G, Schipper, L J, Roepman, P, Bosch, L J W, Lalezari, F, Klompenhouwer, E G, de Langen, A J, Buffart, T E, Riethorst, I, Schoenmaker, L, Schout, D, van der Noort, V, van den Berg, J G, de Bruijn, E, van der Hoeven, J J M, van Snellenberg, H, van der Kolk, L E, Cuppen, E, Voest, E E, Meijer, G A & Monkhorst, K 2022, ' Feasibility of whole-genome sequencing-based tumor diagnostics in routine pathology practice ', Journal of Pathology, vol. 258, no. 2, pp. 179-188 . https://doi.org/10.1002/path.5988
Samsom, K G, Schipper, L J, Roepman, P, Bosch, L J W, Lalezari, F, Klompenhouwer, E G, de Langen, A J, Buffart, T E, Riethorst, I, Schoenmaker, L, Schout, D, van der Noort, V, van den Berg, J G, de Bruijn, E, van der Hoeven, J J M, van Snellenberg, H, van der Kolk, L E, Cuppen, E, Voest, E E, Meijer, G A & Monkhorst, K 2022, ' Feasibility of whole-genome sequencing-based tumor diagnostics in routine pathology practice ', Journal of Pathology, vol. 258, no. 2, pp. 179-188 . https://doi.org/10.1002/path.5988
The current increase in number and diversity of targeted anticancer agents poses challenges to the logistics and timeliness of molecular diagnostics (MolDx), resulting in underdiagnosis and treatment. Whole-genome sequencing (WGS) may provide a susta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78c6dd8cc4558422774c2363cc2462e3
http://www.scopus.com/inward/record.url?scp=85135241312&partnerID=8YFLogxK
http://www.scopus.com/inward/record.url?scp=85135241312&partnerID=8YFLogxK
Autor:
Edwin Cuppen, Olivier Elemento, Richard Rosenquist, Svetlana Nikic, Maarten IJzerman, Isabelle Durand Zaleski, Geert Frederix, Lars-Åke Levin, Charles G. Mullighan, Reinhard Buettner, Trevor J. Pugh, Sean Grimmond, Carlos Caldas, Fabrice Andre, Ilse Custers, Elias Campo, Hans van Snellenberg, Anna Schuh, Hidewaki Nakagawa, Christof von Kalle, Torsten Haferlach, Stefan Fröhling, Vaidehi Jobanputra
Publikováno v:
JCO Precision Oncology, 6:e2200245. American Society of Clinical Oncology
PURPOSE The combination of whole-genome and transcriptome sequencing (WGTS) is expected to transform diagnosis and treatment for patients with cancer. WGTS is a comprehensive precision diagnostic test that is starting to replace the standard of care
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ab7342a6ac09f124157318383a1ca48
https://pubmed.ncbi.nlm.nih.gov/36480778
https://pubmed.ncbi.nlm.nih.gov/36480778
Autor:
Edwin Cuppen, Katrien Grünberg, Valesca P. Retèl, Clémence T. B. Pasmans, Veerle M.H. Coupé, Geert W.J. Frederix, Stefan M. Willems, Eiko K. de Jong, Elisabeth M. P. Steeghs, Bastiaan B. J. Tops, Ed Schuuring, Ewart de Bruijn, Marjolijn J. L. Ligtenberg, Hans van Snellenberg
Publikováno v:
Expert Review of Pharmacoeconomics and Outcomes Research, 21, 3, pp. 413-414
Expert Review of Pharmacoeconomics and Outcomes Research, 21(3), 413-414. Taylor and Francis Ltd.
Pasmans, C T B, Tops, B B J, Steeghs, E M P, Coupé, V M H, Grünberg, K, de Jong, E K, Schuuring, E M D, Willems, S M, Ligtenberg, M J L, Retèl, V P, van Snellenberg, H, de Bruijn, E, Cuppen, E & Frederix, G W J 2021, ' Micro-costing diagnostics in oncology : from single-gene testing to whole-genome sequencing ', Expert Review of Pharmacoeconomics and Outcomes Research, vol. 21, no. 3, pp. 413-414 . https://doi.org/10.1080/14737167.2021.1917385
Expert Review of Pharmacoeconomics and Outcomes Research, 21, 413-414
Expert Review of Pharmacoeconomics and Outcomes Research, 21(3), 413-414. Taylor & Francis
Expert review of pharmacoeconomics & outcomes research, 21(3), 403-414. Taylor & Francis Group
Expert Review of Pharmacoeconomics and Outcomes Research, 21(3), 413-414. Taylor and Francis Ltd.
Pasmans, C T B, Tops, B B J, Steeghs, E M P, Coupé, V M H, Grünberg, K, de Jong, E K, Schuuring, E M D, Willems, S M, Ligtenberg, M J L, Retèl, V P, van Snellenberg, H, de Bruijn, E, Cuppen, E & Frederix, G W J 2021, ' Micro-costing diagnostics in oncology : from single-gene testing to whole-genome sequencing ', Expert Review of Pharmacoeconomics and Outcomes Research, vol. 21, no. 3, pp. 413-414 . https://doi.org/10.1080/14737167.2021.1917385
Expert Review of Pharmacoeconomics and Outcomes Research, 21, 413-414
Expert Review of Pharmacoeconomics and Outcomes Research, 21(3), 413-414. Taylor & Francis
Expert review of pharmacoeconomics & outcomes research, 21(3), 403-414. Taylor & Francis Group
PurposePredictive diagnostics play an increasingly important role in personalized medicine for cancer treatment. Whole genome sequencing (WGS) based treatment selection is expected to rapidly increase worldwide. Detailed and comparative cost analyses
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f66fd597bbfc2a0732307af18e3d213
https://doi.org/10.1080/14737167.2021.1917385
https://doi.org/10.1080/14737167.2021.1917385